General
Preferred name
STANOZOLOL
Synonyms
CPD000058878 ()
Stanozolol ()
Androstanazol ()
WIN 14833 ()
Stanozolol ciii ()
Winstrol Depot ()
NSC-43193 ()
WIN-14833 ()
Stromba ()
Winstrol ()
Androstanazole ()
Tevabolin ()
NSC-233046 ()
P&D ID
PD002859
CAS
10418-03-8
302-96-5
Tags
natural product
drug
available
Approved by
FDA
First approval
1962
Drug Status
withdrawn
approved
vet_approved
Max Phase
Phase 4
Drug indication
Androgen
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Stanozolol is a synthetic, orally active steroid that has anabolic and androgenic properties . Chemically, it is a 17α-alkylated derivative of . It has low binding affinity for the androgen receptor, but is a strong activator of androgen receptor-induced protein synthesis and erythropoietin production . (GtoPdb)
Compound Sets
14
Bioprocess diversity set
Cayman Chemical Bioactives
21167
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
CHEMBL2079587
ChEMBL Drugs
CHEMBL2079587
DrugBank
DB06718
DrugBank Approved Drugs
DB06718
DrugCentral
2477
DrugCentral Approved Drugs
2477
Guide to Pharmacology
10369
LSP-MoA library (Laboratory of Systems Pharmacology)
CHEMBL2079587
NIH Clinical Collections (NCC)
Prestwick Chemical Library
Withdrawn 2.0
1351
External IDs
34
Properties
(calculated by RDKit )
Molecular Weight
328.25
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
5
Aromatic Ring Count
1
cLogP
4.12
TPSA
48.91
Fraction CSP3
0.86
Chiral centers
7.0
Largest ring
6.0
QED
0.75
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Biological process
Resipration, oxidative phosphorylation, & mitochondrial targeting
MOA
Androgen Receptor agonist
Target
Androgen Receptor
ATC
A14AA02
Source data